Cargando…

Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients

The chemokine CCL22 recruits regulatory T (T-reg) cells into tumor tissues and is expressed in many human tumors. However, the prognostic role of CCL22 in cervical cancer (CC) has not been determined. This study retrospectively analyzed the clinical significance of the expression of CCL22 and FOXP3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qun, Schmoeckel, Elisa, Kost, Bernd P., Kuhn, Christina, Vattai, Aurelia, Vilsmaier, Theresa, Mahner, Sven, Mayr, Doris, Jeschke, Udo, Heidegger, Helene Hildegard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966573/ https://www.ncbi.nlm.nih.gov/pubmed/31842422 http://dx.doi.org/10.3390/cancers11122004

Ejemplares similares

CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model
por: Wang, Qun, et al.
Publicado: (2022)

Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2021)

Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients
por: Wang, Qun, et al.
Publicado: (2021)

EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer
por: Buchholz, Anna, et al.
Publicado: (2021)

The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases
por: Dietlmeier, Sebastian, et al.
Publicado: (2020)

L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of G(i)- Protein- Coupled Receptors
por: Tremmel, Eileen, et al.
Publicado: (2020)

Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2020)

Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer
por: Kaltofen, Till, et al.
Publicado: (2020)

Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)

The Prostaglandin EP3 Receptor Is an Independent Negative Prognostic Factor for Cervical Cancer Patients
por: Heidegger, Helene, et al.
Publicado: (2017)

Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer
por: Garrido, Fabian, et al.
Publicado: (2023)

Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
por: Vattai, Aurelia, et al.
Publicado: (2017)

The role of EP-2 receptor expression in cervical intraepithelial neoplasia
por: Schmoeckel, Elisa, et al.
Publicado: (2020)

MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
por: Eppich, Simon, et al.
Publicado: (2020)

MSX1-expression during the different phases in healthy human endometrium
por: Eppich, Simon, et al.
Publicado: (2023)

Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation
por: Vogelsang, Tilman L. R., et al.
Publicado: (2020)

Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2022)

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2021)

The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer
por: Zehni, Alaleh Zati, et al.
Publicado: (2021)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer
por: Zheng, Mingjun, et al.
Publicado: (2021)

LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients
por: Wanka, Giulia, et al.
Publicado: (2020)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages
por: Gratz, Michael J, et al.
Publicado: (2018)

Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile
por: Zheng, Mingjun, et al.
Publicado: (2020)

Cytoplasmic Localization of Thyroid Hormone Receptor (TR) Alpha and Nuclear Expression of Its Isoform TRα2 Determine Survival in Breast Cancer in Opposite Ways
por: Schneider, Mariella, et al.
Publicado: (2023)

PPARγ Expression Is Diminished in Macrophages of Recurrent Miscarriage Placentas
por: Kolben, Theresa Maria, et al.
Publicado: (2018)

Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
por: Tremmel, Eileen, et al.
Publicado: (2019)

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer
por: Vogelsang, Tilman L. R., et al.
Publicado: (2021)

Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality
por: Zati zehni, Alaleh, et al.
Publicado: (2019)

TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC
por: Stavrou, Stavroula, et al.
Publicado: (2018)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017)

MTA1 as negative prognostic marker in vulvar carcinoma
por: Wanka, Giulia, et al.
Publicado: (2023)

Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
por: Ye, Yao, et al.
Publicado: (2020)

EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
por: Zati Zehni, Alaleh, et al.
Publicado: (2020)

Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer
por: Zati zehni, Alaleh, et al.
Publicado: (2021)

Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
por: Vilsmaier, Theresa, et al.
Publicado: (2020)

CCL1 is a major regulatory T cell attracting factor in human breast cancer
por: Kuehnemuth, Benjamin, et al.
Publicado: (2018)

RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro
por: Vogelsang, Tilman L. R., et al.
Publicado: (2023)

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
por: Trebo, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_82nh2aggt11api6f872cksg7o3